| Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
| Treatment success | |||||
|
Systematic review |
1306 people 14 RCTs in this analysis |
Proportion of people with treatment failure
with antithyroid drug plus radioiodine with radioiodine alone |
RR 1.28 95% CI 1.07 to 1.52 P = 0.006 Intention-to-treat analysis |
Small effect size | radioiodine alone |
|
Systematic review |
1306 people 14 RCTs in this analysis |
Proportion of people with treatment failure
with antithyroid drug plus radioiodine with radioiodine alone Absolute results not reported |
RR 1.34 95% CI 0.96 to 1.88 P = 0.09 Per-protocol analysis |
Not significant | |
|
Systematic review |
565 people 14 RCTs in this analysis Subgroup analysis |
Proportion of people with treatment failure
77/271 (28%) with adjuvant antithyroid treatment in the week before radioiodine treatment 55/294 (19%) with radioiodine alone |
RR 1.48 95% CI 1.09 to 2.00 P = 0.01 |
Small effect size | radioiodine alone |
|
Systematic review |
565 people 14 RCTs in this analysis Subgroup analysis |
Proportion of people with treatment failure
191/442 (43%) with adjuvant antithyroid treatment in the week after radioiodine treatment 116/435 (26%) with radioiodine alone |
RR 1.32 95% CI 1.04 to 1.68 P = 0.03 |
Small effect size | radioiodine alone |